What is the current stock price of Kneat.com, Inc. (KSIOF)?

As of the latest market data, Kneat.com, Inc. (KSIOF) is trading at $2.65. The stock has seen a loss of 0.00% today.

Does Kneat.com, Inc. (KSIOF) pay a dividend?

Based on current data, Kneat.com, Inc. does not have a confirmed active dividend policy.

What is the market cap of Kneat.com, Inc.?

The current market capitalization of Kneat.com, Inc. (KSIOF) is approximately unavailable.

KSIOF

Kneat.com, Inc.·Healthcare

2.65

0.000%(+0.00)

Market Closed

Last Updated: — ET

52W L: $2.2552W H: $5.00

KSIOF NEWS

seekingalpha.com

Feb 26

kneat.com, inc. (KSI:CA) Q4 2025 Earnings Call Transcript

globenewswire.com

Feb 25

Kneat Releases 2025 Annual Shareholder Letter Highlighting Resilience, Opportunities Presented by Artificial Intelligence

LIMERICK, Ireland, Feb. 25, 2026 (GLOBE NEWSWIRE) -- kneat.com, inc. (TSX: KSI) (OTCQX: KSIOF) (“Kneat” or the “Company”) a leader in digitizing and automating validation and quality processes, today released its annual shareholder letter highlighting the durability of its growth over the course of a complex year for life sciences companies and the opportunities ahead.

globenewswire.com

Feb 25

Kneat Achieves Record Revenue for Fourth Quarter and Full Year 2025

LIMERICK, Ireland, Feb. 25, 2026 (GLOBE NEWSWIRE) -- kneat.com, inc. (TSX: KSI) (OTCQX: KSIOF) (“Kneat” or the “Company”) a leader in digitizing and automating validation and quality processes, today announced financial results for the fourth quarter and full year ended December 31, 2025.

defenseworld.net

Feb 24

kneat.com (OTC:KSIOF) Trading Down 0.1% – Here’s What Happened

kneat.com, inc. (OTC: KSIOF - Get Free Report) shares were down 0.1% on Monday. The stock traded as low as $2.9850 and last traded at $3.0160. Approximately 11,033 shares were traded during mid-day trading, a decline of 50% from the average daily volume of 21,912 shares. The stock had previously closed at $3.02. Wall Street

globenewswire.com

Feb 19

Global Pharmaceutical Packaging Manufacturer Selects Kneat

LIMERICK, Ireland, Feb. 19, 2026 (GLOBE NEWSWIRE) -- kneat.com, inc. (TSX: KSI) (OTCQX: KSIOF), the global leader in digital validation and quality process automation, today announced it has signed a Master Services Agreement with a U.S.-headquartered global pharmaceutical packaging and drug-delivery manufacturer.

globenewswire.com

Feb 4

Kneat to Announce 2025 Fourth-Quarter and Year-End Financial Results February 25, 2026

Kneat will release its financial results for the quarter ended December 31, 2025 on February 25, 2026 and host a conference call on February 26, 2026.

Company Profile

kneat.com, inc. designs, develops, and supplies software for data and document management within regulated environments in the United States, Ireland, Canada, and internationally. The company offers Kneat Gx platform, a configurable commercial off-the-shelf application focused on validation lifecycle management and testing for biotechnology, pharmaceutical, and medical device manufacturing industries. Its platform is used in process, computer system, cleaning, analytical instrument, method, utility and facility, equipment, and cold chain validation, as well commissioning and qualification, and electronic logbook management. The company also provides software-related services, including training, installation, upgradation, consulting, and maintenance, as well as process mapping, project management, and other services. kneat.com, inc. is headquartered in Limerick, Ireland.

Sector

Healthcare

Industry

Medical - Healthcare Information Services

Employees

297

IPO Date

2014-07-01

Beta

1.23

Websitewww.kneat.com↗